Key result
ACTION score outperforms INTERMACS profile in predicting pediatric VAD mortality with an AUC of ~0.71.
Why the study?
The ACTION score was internally validated to predict mortality after pediatric VAD placement, requiring external validation and performance comparison against the INTERMACS profile in pediatric VAD candidates.
Does the ACTION risk score improve prediction of mortality compared to the INTERMACS profile in pediatric ventricular assist device candidates?
Observational (n=1,835)
Does the ACTION risk score improve prediction of mortality compared to the INTERMACS profile in pediatric ventricular assist device candidates?
The ACTION score is externally validated as a fair predictor of mortality after pediatric VAD placement and outperforms the INTERMACS profile.
Answers are grounded in this paper and cite their sources.
May inform pediatric VAD risk stratification; extends internal validation yet leaves clinical impact open pending prospective data.
The ACTION score was internally validated to predict mortality after pediatric ventricular assist device (VAD) placement. This study aims to externally validate the ACTION score and compare its performance to the INTERMACS profile for prediction of mortality in pediatric VAD candidates. The publicly available Pedimacs dataset (531 patients) was used for external validation. The Pedimacs dataset as well as a contemporary ACTION dataset (1,304 patients) were used to compare the performance of the ACTION score and INTERMACS profile. A statistically significant linear trend in the proportion of death across increasing ACTION scores (p < 0.0001) was observed in the Pedimacs dataset, with a receiver operating characteristic (ROC) curve demonstrating an area under the curve (AUC) of 0.71. Both the ACTION score and the INTERMACS profile demonstrated a significant linear trend in the proportion of death across scores in the ACTION dataset. Receiver operating characteristic analysis demonstrated an AUC of 0.71 and 0.58 for the ACTION score and INTERMACS profile, respectively. The ACTION score is externally validated with the Pedimacs dataset and is a fair predictor of mortality. The ACTION score performed better than the INTERMACS profile in predicting mortality using both historical Pedimacs data and contemporary ACTION data.
No takes yet. Share an insight, caveat, or question.
Reaney et al. (2026) conducted an observational in Pediatric ventricular assist device (VAD) placement (n=1,835). ACTION score vs. INTERMACS profile was evaluated on Mortality after pediatric ventricular assist device (VAD) placement (AUC 0.71, p=<0.0001). The ACTION score was externally validated as a fair predictor of pediatric VAD mortality (AUC 0.71, p<0.0001), outperforming the INTERMACS profile (AUC 0.71 vs 0.58).
Synapse has enriched 10 related papers. Consider them for comparative context: